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Interdependent assembly of specific regulatory lipids
and membrane fusion proteins into the vertex ring
domain of docked vacuoles
Rutilio A. Fratti, Youngsoo Jun, Alexey J. Merz, Nathan Margolis, and William Wickner

THE JOURNAL OF CELL BIOLOGY

Department of Biochemistry, Dartmouth Medical School, Hanover, NH 03755

M

embrane microdomains are assembled by lipid
partitioning (e.g., rafts) or by protein–protein
interactions (e.g., coated vesicles). During docking, yeast vacuoles assemble “vertex” ring-shaped microdomains around the periphery of their apposed
membranes. Vertices are selectively enriched in the Rab
GTPase Ypt7p, the homotypic fusion and vacuole protein
sorting complex (HOPS)–VpsC Rab effector complex,
SNAREs, and actin. Membrane fusion initiates at vertex
microdomains. We now find that the “regulatory lipids”
ergosterol, diacylglycerol and 3- and 4-phosphoinositides
accumulate at vertices in a mutually interdependent man-

ner. Regulatory lipids are also required for the vertex
enrichment of SNAREs, Ypt7p, and HOPS. Conversely,
SNAREs and actin regulate phosphatidylinositol 3-phosphate vertex enrichment. Though the PX domain of the
SNARE Vam7p has direct affinity for only 3-phosphoinositides, all the regulatory lipids which are needed for vertex assembly affect Vam7p association with vacuoles.
Thus, the assembly of the vacuole vertex ring microdomain arises from interdependent lipid and protein partitioning and binding rather than either lipid partitioning
or protein interactions alone.

Introduction
Membrane fusion is catalyzed by conserved factors (Jahn and
Sudhof, 1999), including Rab family GTPases and their effectors
(Chavrier and Goud, 1999), SNAREs (Gerst, 1999), chaperones
such as NSF (Sec18p), -SNAP (Sec17p), and SM proteins
(Fasshauer et al., 1997; Jahn, 2000), and phosphoinositides
(Mayer et al., 2000; Boeddinghaus et al., 2002). The functional
relationships among the proteins and lipids at fusion-competent
microdomains are unknown.
Vacuolar homotypic fusion in Saccharomyces cerevisiae
uses the same mechanisms as other fusion reactions (Wickner
and Haas, 2000). Recent studies reveal a novel spatial arrangement of proteins on docked vacuoles (Wang et al., 2002).
Clustered vacuoles have three membrane subdomains. Regions
of membrane not in contact with other vacuoles are the “outside”
membrane. Docked vacuoles have two flat disc regions of
tightly apposed membranes which are called the “boundary”
Correspondence to Bill Wickner: Bill.Wickner@dartmouth.edu
A.J. Merz’s current address is Dept. of Biochemistry, University of Washington,
Seattle, WA 98195
Abbreviations used in this paper: 3NC, 3-nitrocoumarin; ENTH, epsin NH2-terminal homology domain; HOPS, homotypic fusion and vacuole protein sorting
complex; LatB, latrunculin B; MED, MARCKS effector domain; PI, phosphatidylinositol; PI(3)P, PI 3-phosphate; PX, Phox homology.

© The Rockefeller University Press $8.00
The Journal of Cell Biology, Vol. 167, No. 6, December 20, 2004 1087–1098
http://www.jcb.org/cgi/doi/10.1083/jcb.200409068

membrane. The ring-shaped periphery of the boundary membrane is termed the “vertex”. The vertex is enriched with regulators of vacuole fusion including the Rab Ypt7p, SNAREs,
homotypic fusion and vacuole protein sorting complex
(HOPS), and actin (Eitzen et al., 2002; Wang et al., 2002,
2003). Fusion occurs around the vertex, internalizing boundary
membrane (Wang et al., 2002). Rabs and SNAREs also localize to membrane microdomains in other fusion systems
(TerBush et al., 1996; Roberts et al., 1999; Guo et al., 2001;
Lang et al., 2001).
Vacuole fusion occurs in ordered subreactions. During
priming, Sec17p-bound cis SNARE complexes are disassembled
by Sec18p, releasing both Sec17p (Mayer et al., 1996) and the
soluble SNARE Vam7p (Boeddinghaus et al., 2002). Vam7p
reassociates with vacuoles via its interactions with Ypt7p
(Ungermann et al., 2000) and with phosphatidylinositol (PI)
3-phosphate (PI(3)P) through its PX domain (Cheever et al.,
2001; Boeddinghaus et al., 2002). Docking is initiated by
Ypt7p-dependent tethering, followed by vertex ring assembly.
Docking requires Ypt7p/GTP, HOPS (Price et al., 2000), Rho
GTPases (Eitzen et al., 2001; Muller et al., 2001), and actin
remodeling (Eitzen et al., 2002). Actin remodeling is also regulated by phosphoinositides (Higgs and Pollard, 2000; Rozelle
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et al., 2000). Late stages of vacuole fusion may be mediated by
SNAREs (Nichols et al., 1997; Fukuda et al., 2000), calmodulin (Peters and Mayer, 1998), protein phosphatase 1 (Peters et
al., 1999), V0 complex (Peters et al., 2001), Vtc complex
(Muller et al., 2003), Vac8p (Wang et al., 2001c), actin (Eitzen
et al., 2002) and phosphoinositides (Mayer et al., 2000).
Lipids have specific roles in vacuole fusion. Ergosterol, a
yeast sterol, regulates Sec17p release during priming (Kato and
Wickner, 2001). At least two phosphoinositides regulate fusion. PI(3)P recruits Vam7p to vacuoles (Cheever et al., 2001;
Boeddinghaus et al., 2002), and cells lacking PI 3-kinase have
fragmented vacuoles (Seeley et al., 2002). PI(4,5)P2 also regulates vacuole fusion (Mayer et al., 2000), although by undefined means. PI(4,5)P2 may regulate actin remodeling (Rozelle
et al., 2000), which is required for vertex ring assembly (Wang
et al., 2003) and fusion (Eitzen et al., 2002).
We have now examined lipid spatial distributions on
docked vacuoles and the relationships between regulatory lipids and vertex-enriched fusion proteins. Fluorescent lipid ligands were used to probe the distribution of PI(3)P, PI(4,5)P2,
ergosterol, and DAG. These “regulatory lipids” become enriched at vertices during docking. Antagonists of actin remodeling and SNARE function modified the distribution of PI(3)P,
whereas selective sequestration or enzymatic depletion of regulatory lipids altered the vertex enrichment of other lipids and of
SNAREs, Ypt7p, and HOPS. Thus, lipids and proteins are interdependent for the assembly of a complex membrane docking
junction where fusion occurs.

Results
Vacuole fusion requires PI(3)P (Boeddinghaus et al., 2002),
PI(4,5)P2 (Mayer et al., 2000), ergosterol (Kato and Wickner, 2001), and DAG (Jun et al., 2005). We now use specific
lipid-binding ligands for two different purposes, at either inhibitory concentrations (Fig. 1, closed arrows) or, for probing lipid localization, at subinhibitory concentrations (Fig. 1,
open arrows).
To probe PI(3)P, we use a tandem FYVE domain which
specifically binds PI(3)P (Gillooly et al., 2000). At high concentrations, FYVE inhibits Vam7p reassociation with the
vacuole (Boeddinghaus et al., 2002). FYVE domain derivatized with the fluorophore Cy3 does not inhibit vacuole fusion at 0.2 M (Fig. 1 A). This concentration was used to
monitor PI(3)P localization. To probe PI(4,5)P2, we used
MARCKS effector domain (MED; Wang et al., 2001a) and an
epsin NH2-terminal homology domain (ENTH; Rosenthal et
al., 1999). MED and ENTH inhibited vacuolar fusion at 8 and
30 M (Fig. 1, B and C), consistent with the requirement for
PI(4,5)P2 for vacuole fusion (Mayer et al., 2000). These
ligands showed little inhibition at the low concentrations used
for labeling. DAG was probed with 1 M Alexa488-tagged
C1b domain (Fig. 1 D; Johnson et al., 2000). At higher concentrations (10 M), C1b blocked vacuole fusion (Fig. 1 D).
Fusion is blocked by 19 M filipin (Kato and Wickner,
2001), an intrinsically fluorescent ergosterol ligand (Fig. 1 E).
Like the other ligands, filipin was used at a subinhibitory con1088
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Figure 1. Ligands and enzymes which target phosphoinositides, DAG
and ergosterol inhibit vacuole fusion. Fusion reactions with vacuoles from
BJ3505 and DKY6281 were performed in the absence or presence of the
indicated concentrations of GST-FYVE (A), MED (B), ENTH (C), C1b (D),
Filipin (E), PSS-380 (F), MTM-1 (G), or SigD (H), added from the start of
the reaction. Fusion was assayed by phosphatase activity and expressed
in U. Closed arrows indicate inhibitory concentrations used in this study.
Open arrows indicate sub-inhibitory concentrations used for determining
lipid localization.

centration for labeling. As a probe for phosphatidylserine
(PS), which is not required for vacuole fusion (Mayer et al.,
2000), we used the fluor PSS-380 (Koulov et al., 2003) which
did not affect vacuole fusion (Fig. 1 F). The role of regulatory
lipids was further established using lipid-modifying enzymes.
MTM-1 hydrolyzes the D3 phosphate of PI(3)P (Taylor et al.,
2000), and SigD hydrolyzes the 5-phosphate of PI(4,5)P2
(Marcus et al., 2001). They are potent inhibitors of fusion
(Fig. 1, G and H).
Even high levels of these lipid ligands do not prevent Ypt7p-dependent tethering (Fig. 2). To assay tethering
(Mayer and Wickner, 1997; Wang et al., 2002), vacuoles
were incubated with ATP for 30 min to allow docking into

Selective lipid enrichment at vertices of
docked vacuoles

Figure 2. Regulatory lipids are not required for Ypt7p-dependent tethering.
For quantitative microscopic assay of docking (Mayer and Wickner,
1997), vacuoles were incubated with PS buffer or treated with 2.8 M
Gdi1p and 11.4 M Gyp1-46p for 10 min at 27C in the absence of
ATP. Aliquots were then added to chilled tubes containing docking buffer,
2 M GST-FYVE, 10 M MED, 30 M ENTH, 10 M C1b or 19 M filipin.
Reactions were supplemented with the docking reaction ATP-regenerating
system and returned to 27C for 20 min. After incubation, docking reactions were placed on ice, incubated for 2 min with FM4-64 and mounted
on slides for analysis. For each condition, 10 random fields were scored
for cluster size. Vacuole clusters (A, black bars) include some vacuoles of
enlarged diameter, reflecting fusion (not depicted).

clusters. Random microscopic fields were photographed and
scored for vacuoles per cluster. Though most vacuoles participate in cluster formation (Fig. 2 A, black bars), clustering
was blocked by Ypt7p extraction by Gdi1p, aided by the
GAP Gyp1-46 (gray bars). Vacuole docking is followed by
fusion, lowering the number of vacuoles per cluster; thus this
assay only provides a minimal estimate of docking. Blocking
fusion by lipid ligands enhances the number of vacuoles per
cluster (Fig. 2 B-E, black bars). Nevertheless, this is authentic docking as it is blocked by Ypt7p extraction. Filipin inhibits at multiple stages of the vacuole fusion pathway including priming (Kato and Wickner, 2001), and this parallel
slowing of each reaction stage yielded a distribution of vacuoles per cluster (Fig. 2 F) that resembled the uninhibited reaction (Fig. 2 A). The clustering of filipin treated vacuoles
was still inhibited by inactivation of Ypt7p. Thus, we used
lipid ligands to quantify the distribution of relevant proteins
and lipids on vacuoles which were tethered via the physiological pathway.

Because SNAREs, Ypt7p, HOPS, and actin become enriched at
vertices (Eitzen et al., 2002; Wang et al., 2002, 2003), we examined the distribution of regulatory lipids by monitoring the
distribution of fluorescent lipid-specific probes on docked vacuoles. Cy3-FYVE labeling shows that PI(3)P is enriched at
many vertices (Fig. 3, C and D). Similarly, Cy3-ENTH (Fig. 3,
F and G), filipin (Fig. 3, I and J), and Alexa488-C1b (Fig. 3, L
and M) were concentrated at vertices. While the lipids required
for vacuole fusion are enriched at vertices, PS is evenly distributed (Fig. 3, O and P), as are the nonspecific dyes MDY-64
(Fig. 3, B and E) and FM4-64 (Fig. 3, H, K, and N).
To quantify regulatory lipid enrichment, we used ratiometric fluorescence microscopy (Wang et al., 2002, 2003),
comparing the concentration of each lipid at vertex sites to either FM4-64 or MDY-64. The specific-to-nonspecific probe ratios were normalized to yield a mean value of 1 at the outside
membrane of docked vacuoles. Consequently, the values for
boundary and vertex sites indicate enrichment or depletion of
specific lipids with respect to the outside membrane (Wang et
al., 2002). Ratio values were determined at every vertex,
boundary midpoint, and outer membrane midpoint for over 10
clusters of docked vacuoles. The ratiometric assay (Wang et
al., 2002, 2003) shows 1.2–4-fold mean lipid and protein enrichment at vertices. These are lower bounds estimates of the
enrichments for three reasons. First, the variability among vertex sites reflects the asynchrony of vertex assembly. Fully mature vertex sites may be closer to fusion, and hence have
shorter half-lives, than partially assembled sites. This is underscored by the finding (Fig. 6 B, below) that late fusion stage inhibitors yield dramatically higher vertex enrichment values.
Second, vertices may be below the diffraction limit. Third, relatively low levels of fluorescence are obtained, particularly
with GFP-tagged proteins expressed under native promoters.
Each of these factors increases the noise level (Inoue and
Spring, 1997) and thereby attenuates the maximal observed enrichment values. Notably, other studies of SNARE (Lang et al.,
2001) and Rab GTPase (Roberts et al., 1999) localization during docking in mammalian cells have reported mean enrichments of approximately twofold, similar to our values. Each of
these measurements provide conservative indices of the actual
accumulation at docking sites.
The ratio data for each treatment, probe, and morphological location are shown in cumulative distribution plots
where individual measurements are ranked, then each is plotted at its rank percentile (Fig. 4, A–F). Cy3-FYVE, and thus
PI(3)P, was enriched at vertices (Fig. 4 A). Similarly, rhodamine-MED and Cy3-ENTH, and thus PI(4,5)P2, were
also vertex enriched (Fig. 4, B and C). Filipin, an ergosterolbinding drug, and Alexa488-C1b, a DAG probe, were also enriched at vertices (Fig. 4, D and E). In contrast, PSS-380
(Koulov et al., 2003) was not enriched at vertex or boundary
regions (Fig. 4 F), showing the selectivity of vertex lipid enrichment. In sum, PI(3)P, PI(4,5)P2, DAG, and ergosterol, but
not PS, accumulate at vertex sites. Fig. 4 G shows the geometric means and 95% confidence intervals for these means
LIPIDS AT THE VACUOLE VERTEX RING • FRATTI ET AL.
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Figure 3. Lipids are enriched at the vertices of docked
vacuoles. Vacuoles from DKY6281 yeast were incubated
under docking conditions for 30 min at 27C with fluorescent lipid ligands. After incubation, docking reactions
were placed on ice and labeled with either FM4-64 or
MDY-64. (A) Outer membrane, boundary membrane and
vertex ring subdomains of docked vacuoles. (B and E)
MDY-64 or (H, K, and N) FM4-64 label the entire membrane. Specific lipids were labeled with (C) 0.2 M Cy3FYVE to label PI(3)P, (F) 0.6 M Cy3-ENTH to label
PI(4,5)P2, (I) 5 M filipin to label ergosterol, (L) 1 M
Alexa488-C1b to label DAG, or (O) 2.5 M PSS-380 to
label PS. For Cy3-ENTH labeling, vacuoles were reisolated (5,220 g, 4C, 5 min) at the end of the 30-min incubation to eliminate background fluorescence from unbound probe and resuspended in the original volume of
PS buffer before labeling with MDY-64 and analysis. D,
G, J, M, and P show merged images of nonspecific and
specific probes. Closed arrows are examples of vertex
sites enriched in the specified regulatory lipid. Open arrows are outer membrane microdomains. Bars, 2 m. As
shown below (Fig. 9), ENTH displaces Vam7p from membranes after 90 min under fusion conditions which are
different from the docking conditions and time (30 min)
used here.

for the data in Fig. 4 (A–F). As shown below, the recruitment
of these lipids is subject to complex regulation.
Interdependence of SNAREs and lipids
for vertex assembly

We monitored PI(3)P distribution when other vertex-enriched
lipids were sequestered by ligands. The addition of C1b,
MED, ENTH, or filipin inhibited PI(3)P vertex enrichment
(P  0.00001; Fig. 5 A). Lipid ligands also affected ergosterol
vertex enrichment. Filipin staining showed that ergosterol was
enriched at vertices (Fig. 4, D and G). ENTH blocked ergosterol vertex enrichment (P  0.01; Fig. 5 B), showing that
PI(4,5)P2 is required for ergosterol vertex accumulation. In
contrast, the PI(3)P ligand PX augmented ergosterol levels at
vertices (P  0.001; Fig. 5 B), suggesting either that PI(3)P
inhibits ergosterol vertex enrichment or that inhibition of
1090
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fusion by PX domain prevents fusion-triggered dissociation
of assembled vertices. Though MED is bound mainly to
PI(4,5)P2 in cells (McLaughlin et al., 2002), it can also bind
PI(3,4)P2 (Wang et al., 2001a), PI(4)P (Seki et al., 1996) and
PI(3)P (unpublished data). Apparently, the positive effect of
MED on ergosterol vertex enrichment (by blocking fusioninduced vertex loss) and the negative effect (through sequestration of PI(4,5)P2) are balanced. C1b only had a minor effect
on ergosterol accumulation at vertices, suggesting that DAG is
not required for ergosterol enrichment. Though C1b blocked
PI(3)P localization to vertices (Fig. 4 A), PI(3)P is presumably
not needed for ergosterol enrichment at vertices because ergosterol enrichment is not inhibited by PX domain. These
effects could occur directly, through disruption of lipid microdomain architecture, or indirectly through lipid binding
proteins such as Vam7p.

Figure 4. Quantitation of lipid enrichment at vertices. Docking reactions were performed as in Fig. 3. After 30 min at 27C with fluorescent lipid ligands,
reactions were placed on ice, labeled with either FM4-64 or MDY-64, and analyzed. Cumulative distribution plots depict the percentile values of each
specific lipid ligand/nonspecific lipophilic dye ratio for each of the three microdomains. Each curve is comprised of measurements from 10 vacuole clusters where the maximum intensity was determined for every vertex and midpoint of boundary and outer membrane. Intensities were measured in both fluorescence channels at each subdomain and are expressed as a ratios of specific to nonspecific label. Outer membrane ratios were normalized to a value
of 1 and the enrichment of specific label at vertices and boundaries were expressed relative to outer membrane intensities. Each ratio in a dataset is
ordered and plotted versus the percentile rank of the values. Lipids were labeled with the same concentrations of ligands as in Fig. 3. (G) Geometric
means with their 95% confidence intervals for the data from the cumulative distribution plots in A–F.

We next examined whether protein fusion catalysts affect
the vertex enrichment of regulatory lipids. To test the effect of
SNAREs, we exploited recombinant Sec17p which, at high concentrations, drives unpaired SNAREs into cis complexes (Wang
et al., 2000) and competes with HOPS for binding to SNARE
complexes (K. Collins, personal communication). Excess Sec17p
reduced Cy3-FYVE enrichment at vertices (P  0.0001; Fig. 6
A). This was reversed when excess Sec18p was present (Fig. 6
A), establishing the specificity of Sec17p action. Anti-Vam3p,
which blocks SNARE vertex enrichment (Wang et al., 2003),
also prevented PI(3)P vertex enrichment (P  0.00001; Fig. 6
A), confirming the role of SNAREs in PI(3)P function.

Actin accumulates at vertices (Eitzen et al., 2002; Wang
et al., 2003) and its remodeling is required for SNARE vertex
enrichment (Wang et al., 2003). To determine whether actin remodeling affects PI(3)P vertex enrichment, we used drugs to
either stabilize F-actin or prevent its formation. Jasplakinolide
prevents depolymerization by stabilizing F-actin (Morton et al.,
2000) and blocks vacuole fusion (Eitzen et al., 2002). Although
jasplakinolide has no effect on the vertex enrichment of Ypt7p
(Wang et al., 2003), it reduced Cy3-FYVE vertex enrichment
(P  0.01; Fig. 6 B). In contrast, latrunculin B (LatB), which
prevents actin polymerization (Ayscough, 2000), increased
Cy3-FYVE labeling at vertices (P  0.0001; Fig. 6 B). LatB
LIPIDS AT THE VACUOLE VERTEX RING • FRATTI ET AL.
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Figure 5. Interdependence of the vertex enrichment of regulatory lipids.
Docking reactions were labeled with (A) 0.2 M Cy3-FYVE or (B) 5 M filipin and incubated with either 30 M ENTH, 10 M MED, 10 M C1b,
19 M filipin, 25 M PX, or buffer alone. After 30 min at 27C, reactions
were placed on ice, labeled with MDY-64 (A) or FM4-64 (B), and prepared for fluorescence microscopy. Relative enrichments of specific probes
were determined as in Fig. 3. Data are presented as geometric mean
values  95% confidence intervals of the relative enrichment at vertices.

does not alter the vertex enrichment of Vam3p (Wang et al.,
2003). Actin depolymerization may promote PI(3)P enrichment at vertices, and repolymerization may either inhibit
PI(3)P vertex enrichment or allow its dispersal during fusion.
As a control, we tested vacuoles from cells bearing the act1113 mutation, which confers resistance to latrunculin (Ayscough et al., 1997), or from isogenic ACT1 cells. LatB had no
effect on Cy3-FYVE vertex enrichment on act1-113 derived
vacuoles (Fig. 6 C), though it enhanced Cy3-FYVE vertex labeling on vacuoles from the ACT1 parent strain (P  0.0001;
Fig. 6 C), showing that the effects of LatB on PI(3)P were due
to alterations in actin polymerization. The vertex enrichment of
PI(3)P on docked ACT1 or act1-113 vacuoles showed similar
responses to other ligands such as ENTH, indicating that the
mobilization of PI(3)P to vertices is otherwise unaffected by
the act1-113 mutation.
Although C1b inhibited PI(3)P vertex enrichment, and one
pathway to DAG is through hydrolysis of PI(4,5)P2 by PLC, it
remained unclear whether PLC activity might affect vertex ring
assembly. To address this, we used 3-nitrocoumarin (3NC) to
inhibit PLC activity (Tisi et al., 2001). 3NC dramatically increased Cy3-FYVE labeling at vertices (P  0.0001; Fig. 6 B),
which was not seen with the inactive analogue 7-OH-3NC (not
depicted). Vacuolar fusion is inhibited by 3NC but not by
7-OH-3NC (Jun et al., 2005), suggesting that PLC activity is required for vacuole fusion but not for vertex enrichment of
PI(3)P. The enhancement of PI(3)P vertex enrichment by LatB
or 3NC, which block the late stages of fusion, suggests that
PI(3)P vertex enrichment may be lost during or after fusion.
Lipids govern the vertex enrichment of
fusion regulatory proteins

Because regulatory lipids depend on each other and on fusion proteins for vertex enrichment (Figs. 5 and 6), we asked
whether fusion protein vertex enrichment may depend on
regulatory lipids. We examined the effect of lipid ligands on
vertex enrichment of Ypt7p, the SNAREs Vam7p, Vam3p,
and Vti1p, and the HOPS subunit Vps33p. Ypt7p vertex en1092
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Figure 6. Protein ligands affect PI(3)P localization. (A and B) Docking
reactions using DKY6281 vacuoles labeled with 0.2 M Cy3-FYVE (as described in Figs. 2 and 3) were treated with 750 nM (excess) Sec17p, 1.2
M Sec18p, both excess Sec17p and Sec18p, 190 nM anti-Vam3 Fab,
0.5 mM jasplakinolide, 0.8 mM LatB, 11.4 M Gyp1-46p (Gyp), or 250
M 3NC. After 30 min at 27C, reactions were placed on ice and prepared for fluorescence microscopy. Geometric mean values  95% confidence intervals of the relative enrichment at vertices are shown. (C) To
determine whether the effects of LatB were due to alterations in actin polymerization, vacuoles were harvested from isogenic DDY182 yeast containing Act1 or the latrunculin resistant mutant act1-113 and used in docking
experiments. Vacuoles were labeled with Cy3-FYVE and incubated during
docking reactions with 0.8 mM LatB or 30 M ENTH where indicated.
Samples were prepared and analyzed as in Figs. 2 and 3.

richment is impervious to several protein-targeted inhibitors
of fusion (Wang et al., 2003), yet was blocked by ENTH,
C1b, FYVE, or filipin (P  0.0001; Fig. 7 A). The inhibition
of Ypt7p enrichment by FYVE contrasts with the previous
finding that the PI(3)P ligand PX domain did not affect
Ypt7p vertex accumulation (Wang et al., 2003). This may reflect a greater affinity of dimeric FYVE than monomeric PX
for PI(3)P.

Figure 7. Regulatory lipids control the vertex enrichment of Ypt7p, SNAREs, and HOPS. Docking reactions using vacuoles from strains expressing GFP
fusions to Ypt7p (A), Vam7p (B), Vam3p (C), Vti1p (D), Vps33p (E), or Pho8p (F) were treated with 30 M ENTH, 10 M MED, 10 M C1b, 19 M filipin,
25 M PX, or 2 M GST-FYVE and assayed for vertex enrichment. Reactions were incubated for 30 min at 27C, placed on ice and labeled with FM4-64.
Geometric mean values  95% confidence intervals of relative vertex enrichment are shown. (G–R) Fluorescent images of docked vacuoles containing
GFP-Vti1p (G–L), or GFP-Ypt7p (M–R). Docking reactions bore no inhibitor (G–I and M–O) or 30 M ENTH (J–L and P–R). G, J, M, and P show membrane
staining with FM4-64. H, K, N, and Q show the distribution of GFP-Vti1p (H and K) or GFP-Ypt7p (N and Q). Merged images illustrate the enrichment of
GFP-Vti1p (I) and Ypt7p (O) at vertices relative to outer membrane. ENTH treatment abolished the vertex enrichment of these proteins (L and R). Arrows are
examples of vertices enriched in GFP-Vti1 (H and I) and GFP-Ypt7 (N and O) relative to outer membrane. Bars, 5 m.

Because SNAREs accumulate at vertices (Wang et al.,
2003), we examined the roles of regulatory lipids on this process. The PI(3)P ligands FYVE and PX displace Vam7p from
membranes (Boeddinghaus et al., 2002) and hence from vertices (Wang et al., 2003). Vam7p vertex localization was also
suppressed by ENTH, C1b or filipin (P  0.0001; Fig. 7 B).
Because these lipid ligands reduce PI(3)P enrichment at vertices (Fig. 5 A), and Vam7p binds directly to PI(3)P, the other
regulatory lipids may largely affect Vam7p vertex enrichment
through controlling PI(3)P vertex enrichment. Vam3p vertex
enrichment (Wang et al., 2003) was blocked by each regulatory lipid ligand (P  0.01; Fig. 7 C). As Vam3p forms a complex with Vam7p (Ungermann and Wickner, 1998; Ungermann et al., 1999), regulatory lipids may govern Vam3p vertex
enrichment directly or through Vam7p. ENTH, C1b, and
FYVE also inhibited Vti1p vertex enrichment (P  0.0001;
Fig. 7 D). Vti1p does not depend on Vam3p or Vam7p for its
vertex enrichment (Wang et al., 2003). In accord with this divergent SNARE enrichment pathway, Vti1p enrichment was
not significantly affected by filipin (Fig. 7 D) even though fil-

ipin abolished the vertex enrichment of Vam7p and Vam3p
(Fig. 7, B and C). Lipid ligands also inhibited Vps33p vertex
enrichment (P  0.01; Fig. 7 E). Examples of specific protein
enrichment at vertices, and ENTH blockage of enrichment, are
shown in Fig. 7 (G–R).
As a control, we examined the effects of these ligands on
the distribution of Pho8-GFP, a trans-membrane vacuolar protein. Pho8p is not involved in fusion and is evenly distributed
on docked vacuoles (Wang et al., 2002). Simple displacement
of proteins from vertices by lipid ligands would have depleted
Pho8-GFP from vertices. Pho8-GFP was not significantly displaced from vertices by any of the lipid ligands (Fig. 7 F), indicating that the effects of lipid ligands on bona fide fusion protein enrichment are specific.
Enzymatic modification of regulatory
lipids inhibits vertex ring assembly

To complement the above studies, we used lipid modifying enzymes. MTM-1, which inhibits fusion (Fig. 1 G), blocked
Ypt7p vertex enrichment (P  0.00001; Fig. 8 A). This mirrors
LIPIDS AT THE VACUOLE VERTEX RING • FRATTI ET AL.
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Figure 8. Enzymatic modification of regulatory lipids inhibits vertex
assembly. Docking reactions (30 min, 27C), using vacuoles containing
GFP-Ypt7p (A) or vacuoles labeled with Cy3-FYVE to mark PI(3)P (B) or filipin
to mark ergosterol (C), bore 1 M MTM-1, 2 M SigD, 1 U/ml PI-PLC, or
2.7 M Plc1p. After incubation, reactions were placed on ice, counterstained with FM4-64 (A and C) or MDY-64 (B), and prepared for microscopic analysis. Geometric means  95% confidence intervals of the relative
vertex enrichment are shown.

the effect of FYVE domain on Ypt7p enrichment (Fig. 7 A),
and confirms that PI(3)P is essential for Ypt7p vertex enrichment. MTM-1-mediated depletion of PI(3)P enhanced ergosterol enrichment (P  0.01; Fig. 8 C), in accord with our observations using PX (Fig. 5 B). To complement our studies with
ENTH on the role of PI(4,5)P2, we used the PI 5-phosphatase
SigD and PI(4,5)P2 specific lipase Plc1p (Flick and Thorner,
1993). As for ENTH, SigD and Plc1p inhibited the vertex localization of Ypt7p and PI(3)P (Fig. 8, A and B; P  0.00001).
Interestingly, ergosterol vertex enrichment was inhibited by
SigD (P  0.01) but not by Plc1p (Fig. 8 C); the generation of
DAG by Plc1p may slightly stimulate ergosterol enrichment, in
accord with the modest decrease caused by C1b (Fig. 5 B). We
also tested the role of unmodified PI. We have previously
shown that the hydrolysis of PI by PI-PLC inhibits vacuole fusion (Mayer et al., 2000). This inhibition was relieved by the
addition of PI(4,5)P2 (ibid), suggesting that vacuolar PI primarily serves as a source for the synthesis of PI(4)P and PI(4,5)P2.
PI-PLC inhibited vertex enrichment of Ypt7p and PI(3)P (P 
0.00001; Fig. 8, A and B). The similarity of these results with
those seen with Plc1p suggests that PI is needed for PI(4,5)P2
synthesis for vacuole fusion.
Regulatory lipids modulate the vacuolar
association of Vam7p

Lipids are important for the vacuole binding of perpheral
membrane proteins. Soluble Vam7p can be released from
vacuoles after priming (Sato et al., 1998; Ungermann and
Wickner, 1998) and reassociates with vacuoles for docking
(Ungermann et al., 2000). Vam7p lacks an apolar membrane
anchor but has a PI(3)P-interacting PX domain (Cheever et
al., 2001). Vam7p needs both PI(3)P and Ypt7p for stable
membrane binding, after which it binds to Vam3p to promote
fusion (Sato et al., 1998; Ungermann and Wickner, 1998;
Ungermann et al., 2000).
Vacuole sedimentation allowed analysis of the Vam7p
bound to the vacuole or remaining in the supernatant after
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Figure 9. Regulatory lipids are required for vacuolar association of
Vam7p. Vam7p association with vacuolar membranes was assayed by
immunoblot in fusion reactions without inhibitor or with 2 M GST-FYVE,
10 M C1b, 19 M filipin, 38 M GST-ENTH, 2 M SigD, or 1 M
MTM-1. Reactions were also performed in the presence of anti-Sec18p Fab
to inhibit priming. Fusion reactions were incubated for 90 min at 27C,
then fractionated into membrane pellets and supernatants by centrifugation
(13,000 g, 15 min, 4C). Membranes were resuspended in 30 l PS
buffer with protease inhibitors (1 M leupeptin, 5 M pepstatin and 0.1
M pefabloc-SC). (A) Equal proportions of the pellet and supernatant
fractions were mixed with SDS-loading buffer, resolved by SDS-PAGE,
then transferred to nitrocellulose. (B and C) Quantitative analysis of membrane-bound Vam7p by Western blots. Data represent mean values  SEM.
Relative band intensities were measured using NIH Image 1.62 (n  4).

standard fusion incubations without inhibitors or with lipid
modifying enzymes or ligands (Fig. 9). Most of Vam7p is
bound to vacuoles at the end of a fusion reaction. As reported
(Boeddinghaus et al., 2002), FYVE domain caused Vam7p
release. MTM-1 was equally effective at promoting Vam7p
release. Although the Vamp7 PX domain has direct affinity
for only PI(3)P (Cheever et al., 2001), the vacuole association
of Vam7p was blocked by either ENTH, a PI(4,5)P2 ligand, or
by SigD, a PI(4,5)P2 5phosphatase. C1b and Filipin also promote release of Vam7p. These data suggest that Ypt7p and
PI(3)P may promote Vam7p association with vacuoles at vertices. Vam7p release was blocked when priming was inhibited by antibody to Sec18p (Fig. 9 C), showing that lipid
ligands and modifying enzymes are only affecting Vam7p reassociation after it has been released from its associations
with other integral membrane SNARE proteins by Sec18pmediated priming.

Discussion
Our earlier studies explored the role of protein: protein interactions in protein enrichment at vertex microdomains (Wang et
al., 2002, 2003). We now find that the regulatory lipids PI(3)P,
PI(4,5)P2, DAG and ergosterol are required for the assembly of
vertex rings and for vacuole fusion. Each of these lipids is enriched at vertices, demonstrating that fusion catalysts operate
within highly organized membrane domains. The localization
of PI(3)P to vertices is not only dependent on other lipids, but
is regulated by SNAREs. Moreover, the vertex enrichment of
Ypt7p, HOPS and SNAREs as well as the membrane association of Vam7p (Boeddinghaus et al., 2002) are lipid-dependent.
Ergosterol may contribute to vertex assembly by inhibiting the
diffusion of enriched components in this microdomain and
thereby slowing their exit from the vertex (Valdez-Taubas and
Pelham, 2003). The fusion-regulatory lipids and proteins are
mutually interdependent for their vertex enrichment.
Phosphoinositides are also required for other membrane trafficking steps and for the assembly of specific microdomains. Endocytosis (Li et al., 1995), and phagocytosis
(Botelho et al., 2000; Marshall et al., 2001) depend on 3- and
4-phosphoinositides. The endosomal degradative pathway also
requires PI(3)P. PI(3)P participates in the down-regulation of
HGFR (Futter et al., 2001) and in phagolysosome biogenesis
(Fratti et al., 2001). PI(3)P regulates the trafficking of hydrolytic enzymes from the Golgi to endosomes (Brown et al.,
1995) and the formation of multivesicular bodies (Futter et al.,
2001). Early endosome Rab5 recruits the PI3 kinase hVps34
(Christoforidis et al., 1999), forming PI(3)P and recruiting the
tethering factor EEA1. Rab5 and EEA1 form a tethering complex that includes other Rab5 effectors, a SNARE and NSF
(McBride et al., 1999). Rab5 and EEA1 colocalize in microdomains scattered throughout early endosomal membranes (McBride et al., 1999). Although all the components of the early
endosome tethering complex are required for fusion, their coalescence into a single defined microdomain at the site of fusion
has not been demonstrated. On the yeast vacuole, we find that
regulatory lipids, SNAREs, Ypt7p and HOPS self-assemble in
an interdependent manner into a domain which specifies the
site of membrane fusion.
Phosphoinositide localization to sterolrich microdomains

PI(3)P and ergosterol are interdependent for their vertex enrichment (Fig. 5, A and B). Although the role of PI(3)P in lipid
domains has not been exhaustively studied, links between
PI(4,5)P2 function and sterol rich domains are well established.
PI(4,5)P2 concentrates in cholesterol-rich lipid domains in
many cell types (Pike and Casey, 1996; Liu et al., 1998) and
this can affect PI(4,5)P2-interacting molecules. The link between PI function and sterols in higher eukaryotes has parallels
with the regulation of vacuole fusion by lipids. In mammalian
cells, extraction of cholesterol redistributes PI(4,5)P2 (Yamashita et al., 2001) and inhibits EGFR signaling by blocking
PI(4,5)P2 turnover (Pike and Casey, 1996). The redistribution
of PI(4,5)P2 from lipid domains prevents PLC translocation

from cytosol to membranes (Wang et al., 2001b), thereby inhibiting PI(4,5)P2 turnover and the generation of IP3 and DAG
(Jang et al., 2001). The dependence of vacuole fusion on
4-phosphoinositides (Mayer et al., 2000), PLC activity (Jun
et al., 2005), and sterols (Kato and Wickner, 2001) is consistent with the colocalization of phosphoinositides, DAG, and
SNAREs to vacuolar microdomains.
Sterol and phosphoinositide interdependence at vertices is
shown by the enrichment of each of these lipids and the sensitivity of this enrichment to ligands or modifiers of the other regulatory lipids. This model is supported by other studies showing
that SNAREs are concentrated in cholesterol-dependent clusters
that define docking and fusion sites for exocytosis (Lang et al.,
2001). Furthermore the SNAREs SNAP-25 and Syntaxin 1 directly interact with caveolin 1, a resident of caveolae (Magga et
al., 2002). Although these SNAREs are also present throughout
the membrane, they are enriched in specific lipid microdomains. The SNARE synaptobrevin interacts with the cholesterol-binding protein synaptophysin, leading to enhanced synaptobrevin interactions with other SNAREs (Mitter et al.,
2003). Disrupting lipid microdomains interferes with synaptobrevin/synaptophysin interactions and with synaptobrevin complex formation with other SNAREs (Mitter et al., 2003). In sum,
SNARE-mediated membrane fusion requires lipid-regulated microdomains in other systems as well as in vacuoles.
Ypt7p functions near the beginning of the vertex ring assembly cascade (Wang et al., 2003). Although Ypt7p enrichment at vertices is resistant to all previously tested inhibitors of
vacuole fusion (Wang et al., 2003), lipid ligands and modifiers
block Ypt7p accumulation in this domain (Fig. 7 A and Fig. 8
A). Thus regulatory lipids, though not required for Ypt7pdependent vesicle tethering (Fig. 2), are required for Ypt7p
vertex enrichment. We postulate that the initial tethering events
require Ypt7p action at the site of initial vacuole contact. This
is followed by the establishment of a vertex ring of Ypt7p and
the regulatory lipids. The assembly of a fully functional vertex
ring is intricate, and our current understanding of the interdependence of lipids and proteins for ring assembly does not permit simple hierarchical models of their functions.

Materials and methods
Reagents
Reagents were dissolved in PS buffer (20 mM Pipes-KOH, pH 6.8, 200
mM sorbitol). MED (KKKKKRFSFKKSFKLSGFSFKKNKK) labeled with 5,6
carboxytetramethylrhodamine (excitation 546 nm, emission 576 nm) was
from the Keck center (Yale). PSS-380 (excitation 380 nm, emission 440; a
gift from A. Koulav, University of Notre Dame, IN) was dissolved in PS
buffer at 1 mM. Anti-Vam3p Fab (Wang et al., 2003), and anti-Sec18p Fab
(Mayer and Wickner, 1997) were described previously. Filipin III (excitation 337 nm, emission 480 nm; Sigma-Aldrich) was dissolved in DMSO at
1.16 mM. Jasplakinolide (Molecular Probes) and LatB (BIOMOL Research
Laboratories, Inc.) were dissolved in DMSO at 10 mM. 3NC (a gift from
E. Martegani, Universita di Milano, Italy) and 7-OH-3NC (a gift from D.
Thakker, University of North Carolina, NC) were dissolved in DMSO at 3
and 6 mM, respectively. PI-PLC (from Bacillus cereus; Sigma-Aldrich) was
dissolved in PS buffer with 125 mM KCl and 5 mM MgCl2 and passed
over a PD-10 column (Amersham Biosciences) in this buffer.
Recombinant proteins
C1b (plasmid a gift from A. Newton, University of California at San Diego, La Jolla, CA; Johnson et al., 2000), ENTH (plasmid a gift from P. De
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Camilli, Yale University School of Medicine, New Haven, CT; Rosenthal et
al., 1999), PX (Boeddinghaus et al., 2002), and tandem FYVE domain
(plasmid a gift from H. Stenmark, The Norwegian Radium Hospital, Oslo,
Norway; Gillooly et al., 2000) were produced as recombinant GST fusion
proteins in E. coli as described. GST domains were removed by thrombin
(Amersham Biosciences) or factor Xa (New England Biolabs, Inc.) cleavage according to each protease manufacturers’ protocols and proteins
were dialyzed into PS buffer with 125 mM KCl and 5 mM MgCl2. Thrombin and factor Xa were removed from cleavage products by a p-aminobenzamidine-agarose (Sigma-Aldrich) column in PS buffer. FYVE and
ENTH were labeled with Cy3 (excitation 546 nm, emission 570 nm; Research Organics) and C1b was labeled with Alexa488 (excitation 488
nm, emission 519 nm; Molecular Probes) according to the manufacturers’
protocols. His6-MTM-1 (plasmid a gift from J. Dixon, University of California at San Diego, La Jolla, CA; Taylor et al., 2000), his6-SigD (plasmid a
gift from B. Finlay, University of British Columbia, Vancouver, BC, Canada; Marcus et al., 2001), and his6-Plc1p (Flick and Thorner, 1993) were
prepared as described previously and dialyzed into PS buffer with 125
mM KCl and 5 mM MgCl2. His6-Sec17p and his6-Sec18p were prepared
as described previously (Haas and Wickner, 1996). His6-Sec18p was further purified by gel filtration (Thorngren et al., 2004). Gdi1p (Garrett and
Novick, 1995), his6-Gyp1-46p (Wang et al., 2003) and IB2 (Slusarewicz
et al., 1997) were prepared as described.
Vacuole isolation and in vitro fusion assay
Vacuoles were isolated from the yeast strains BJ3505 (Jones, 2002) and
DKY6281 (Haas et al., 1994). Fusion reactions (30 l) contained 3 g of
BJ3505 vacuoles with inactive pro-Pho8p (pro-alkaline phosphatase) but
lacking the protease Pep4p, 3 g of DKY6281 vacuoles containing Pep4p
but lacking Pho8p, standard fusion reaction buffer (125 mM KCl, 5 mM
MgCl2, 20 mM Pipes-KOH, pH 6.8, 200 mM sorbitol), ATP regenerating
system (1 mM ATP, 40 mM creatine phosphate, 0.1 mg/ml creatine kinase), 10 M coenzyme A (Haas et al., 1995) and 930 nM IB2. After 90
min at 27C, Pho8p activity was assayed in 250 mM Tris-Cl, pH 8.5,
0.4% Triton X-100, 10 mM MgCl2, 1 mM p-nitrophenylphosphate. 1 U of
fusion is 1 mol p-nitrophenolate produced per min per g of BJ3505
vacuoles. P-nitrophenolate absorbance was measured at 400 nm.
Vacuole docking assay
GFP-tagged strains and their use in docking assays were described previously (Wang et al., 2002, 2003). Isogenic strains containing the ACT1
wild type and act1-113 mutant alleles were a gift from D. Drubin (University of California at Berkeley, Berkeley, CA; Ayscough, 2000). Docking reactions (30 l) contained 6 g of vacuoles from DKY6281, unless otherwise noted, in 30 l docking reaction buffer (100 mM KCl, 0.5 mM
MgCl2, 20 mM Pipes-KOH, pH 6.8, 200 mM sorbitol), ATP regenerating
system (0.3 mM ATP, 6 mM creatine phosphate, 0.7 mg/ml creatine kinase), 20 M coenzyme A, 930 nM IB2, 8 nM his6-Sec18p and either no
lipid ligand or 0.2 M Cy3-FYVE, 0.6 M ENTH, 5 M filipin, 1 M Alexa 488-C1b, 0.5 M rhodamine-MED, or 2.5 M PSS-380. After 30 min
at 27C, vacuoles bearing GFP-tagged proteins or labeled with filipin,
PSS380, or Alexa488-C1b were place on ice and mixed with 0.7 l of
160 M FM4-64 for 2 min (3.7 M final concentration; Molecular
Probes). Vacuoles labeled with Cy3-FYVE domain or Cy3-ENTH domain
were mixed with 1 l of 16 M MDY-64 (Molecular Probes) for 2 min. For
Cy3-ENTH labeling, vacuoles were reisolated (5,220 g, 4C, 5 min) at the
end of the 30-min incubation to eliminate background fluorescence and resuspended in the original volume of PS buffer before labeling with MDY-64
and microscopic analysis. Vacuoles were then mixed with 50 l of 0.6%
agarose in PS buffer at 42C, vortexed (3 s, medium setting), and 15 l aliquots were mounted on slides and observed by fluorescence microscopy.
Images were acquired using a microscope (model BX51; Olympus)
equipped with a 100W mercury arc lamp, Plan Apochromat 60 objective (1.4 NA) and a Sensicam QE CCD camera (Cooke). Images were acquired at 23C without pixel binning. GFP proteins, Alexa488-C1b and
MDY-64 images were acquired using an Endow GFP filter set (Chroma
Technology Corp.). Cy3-FYVE, Cy3-ENTH, and FM4-64 images were acquired using a TRITC/DiI filter set (Chroma Technology Corp.). An XF06
filter set (Omega Optical, Inc.) was used to acquire filipin and PSS-380
images. Filter sets were housed in a motorized turret. FM4-64 and MDY64 were used to focus fields and photobleaching was performed for 20 s
between channels. Bleaching of specific probes (e.g., filipin), though minimal, was normalized by automated image acquisition using IP Lab software (Scanalytics). Image acquisition scripts, using fixed exposure times,
first captured the nonspecific probe followed by the specific probe. This
method ensures that any bleaching is uniform, and negates it as a factor
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in calculating intensity ratios. Images were processed and analyzed using
Image/J software (NIH). For ratiometric quantitation, maximum pixel values for vertex, boundary and outer membrane were measured in each
fluorescence channel. Every vertex and outer membrane within a vacuole
cluster was measured. Vertex ratio values were normalized by dividing by
the mean ratio values of outside edges. For each treatment, 15–20 clusters with 100–300 vertex sites were analyzed from multiple independent
experiments. The data are presented from a representative experiment in
each case. The range of mean ratio values reflect the daily variability of
our vacuole preparation. However, this does not affect the responsiveness
of vacuoles within each preparation to our panel of inhibitors.
Statistical analysis of vertex enrichment experiments used JMP 5
(SAS Institute, Inc.). Ratio data were log transformed before analysis to
yield near-normal distributions with comparable variances. Ratio means
and 95% confidence intervals were analyzed using one-way ANOVAs for
each lipid ligand and GFP-protein fusion. Significant differences in vertex
enrichment were determined using t test and corrected for multiple comparisons using the Dunn-Sidak method (Sokal and Rohlf, 1994). P-values
less than 0.05 were considered significant.
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